Moll Wenden advised SensoDetect Aktiebolag on the deal. SensoDetect Aktiebolag completed a rights issuance of units amounting to approximately SEK 19.4 million with preferential rights to...
SensoDetect Aktiebolag’s Rights Offering
Scandinavian ChemoTech AB’s Shares Offering
Moll Wenden advised Scandinavian ChemoTech AB on the deal. Scandinavian ChemoTech AB completed the issuance of shares amounting to approximately SEK 14.85 million. ChemoTech is a Swedish medical...